邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

药物诱导硬皮病

黄婧,  李梦涛,  曾小峰

downloadPDF
文章导航 > 协和医学杂志  > 2014 >  5(2): 192-196
黄婧, 李梦涛, 曾小峰. 药物诱导硬皮病[J]. 协和医学杂志, 2014, 5(2): 192-196. doi: 10.3969/j.issn.1674-9081.2014.02.014
引用本文: 黄婧, 李梦涛, 曾小峰. 药物诱导硬皮病[J]. 协和医学杂志, 2014, 5(2): 192-196. doi: 10.3969/j.issn.1674-9081.2014.02.014
shu

药物诱导硬皮病

doi: 10.3969/j.issn.1674-9081.2014.02.014

  • 中国医学科学院 北京协和医学院 北京协和医院风湿免疫科, 北京 100032

基金项目: 

首都医学发展科研基金重点支持项目 2009-2003

、中华医学会临床医学科研专项资金 08010270105

、北京协和医院青年科研基金 1604900

详细信息
    通讯作者:

    李梦涛 电话:010-69158796, E-mail:mengtao.li@cstar.org.cn

  • 中图分类号: R593.25;R595.3

    摘要
    • HTML全文
    • 参考文献(49)
  • [1] Finch WR, Rodnan GP, Buckingham RB, et al. Bleomycin-induced scleroderma[J]. J Rheumatol, 1980, 7:651-659.
    [2] Inaoki M, Kawabata C, Nishijima C, et al. Case of bleomycin-induced scleroderma[J]. J Dermatol, 2012, 39:482-484. doi:  10.1111/j.1346-8138.2011.01301.x
    [3] Yamamoto T, Takagawa S, Katayama I, et al. Animal model of sclerotic skin. Ⅰ:Local injections of bleomycin induce sclerotic skin mimicking scleroderma[J]. J Invest Dermatol, 1999, 112:456-462. doi:  10.1046/j.1523-1747.1999.00528.x
    [4] Yamamoto T, Kuroda M, Nishioka K. Animal model of sclerotic skin. Ⅲ:Histopathological comparison of bleomycin-induced scleroderma in various mice strains[J]. Arch Dermatol Res, 2000, 292:535-541. doi:  10.1007/s004030000183
    [5] Lidar M, Agmon-Levin N, Langevitz P, et al. Silicone and scleroderma revisited[J]. Lupus, 2012, 21:121-127. doi:  10.1177/0961203311430703
    [6] Sozeri B, Gulez N, Aksu G, et al. Pesticide-induced scleroderma and early intensive immunosuppressive treatment[J]. Arch Environ Occup Health, 2012, 67:43-47. doi:  10.1080/19338244.2011.564231
    [7] Pelmear PL, Roos JO, Maehle WM. Occupationally-induced scleroderma[J]. J Occup Med, 1992, 34:20-25. http://www.ncbi.nlm.nih.gov/pubmed/1313094
    [8] Haustein UF, Ziegler V, Herrmann K. Chemically-induced scleroderma[J]. Hautarzt, 1992, 43:469-474. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=b4fd800676a619fec8e019391c30b38c
    [9] Takeda A, Higuchi D, Yamamoto T, et al. Purification and characterization of bleomycin hydrolase, which represents a new family of cysteine proteases, from rat skin[J]. J Biochem, 1996, 119, :29-36. doi:  10.1093/oxfordjournals.jbchem.a021212
    [10] Yamamoto T, Katayama I. Vascular changes in bleomycin-induced scleroderma[J]. Int J Rheumatol, 2011, 2011:270938. http://pubmedcentralcanada.ca/pmcc/articles/PMC3199103/
    [11] Takahashi T, Asano Y, Ichimura Y, et al. A case of taxane-induced scleroderma:a different expression profile of Fli1 proteins in dermal fibroblasts and microvascular endothelial cells compared with systemic sclerosis[J]. Br J Dermatol, 2011, 164:1393-1395. doi:  10.1111/j.1365-2133.2011.10243.x
    [12] Kono T, Ishii M, Negoro N, et al. Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent[J]. J Am Acad Dermatol, 2000, 42:519-520. doi:  10.1016/S0190-9622(00)90233-0
    [13] Shikuwa S, Senju M, Tanaka H, et al. Progressive systemic sclerosis associated with primary small cell carcinoma of the stomach[J]. J Gastroenterol, 1997, 32:538-542. doi:  10.1007/BF02934096
    [14] Kluger N, Girard C, Bessis D, et al. Methysergide-induced scleroderma-like changes of the legs[J]. Br J Dermatol, 2005, 153:224-225. doi:  10.1111/j.1365-2133.2005.06708.x
    [15] Peroni A, Zini A, Braga V, et al. Drug-induced morphea:report of a case induced by balicatib and review of the literature[J]. J Am Acad Dermatol, 2008, 59:125-129. doi:  10.1016/j.jaad.2008.03.009
    [16] Attoussi S, Faulkner ML, Oso A, et al. Cocaine-induced scleroderma and scleroderma renal crisis[J]. South Med J, 1998, 91:961-963. doi:  10.1097/00007611-199810000-00013
    [17] 马佳彬, 王迁, 李梦涛, 等.干扰素诱发的结缔组织病[J].中华风湿病学杂志, 2011, 15:3. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfsbx98201112016
    [18] Zhang K, Gharaee-Kermani M, McGarry B, et al. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis[J]. J Immunol, 1997, 158:954-959. http://europepmc.org/abstract/med/8993016
    [19] Phan SH, Gharaee-Kermani M, Wolber F, et al. Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin[J]. J Clin Invest, 1991, 87:148-154. doi:  10.1172/JCI114964
    [20] Wallace VA, Kondo S, Kono T, et al. A role for CD4+ T cells in the pathogenesis of skin fibrosis in tight skin mice[J]. Eur J Immunol, 1994, 24:1463-1466. doi:  10.1002/eji.1830240634
    [21] Helene M, Lake-Bullock V, Zhu J, et al. T cell independence of bleomycin-induced pulmonary fibrosis[J]. J Leukoc Biol, 1999, 65:187-195. doi:  10.1002/jlb.65.2.187
    [22] Yamamoto T, Nishioka K. Animal model of sclerotic skin. Ⅳ:induction of dermal sclerosis by bleomycin is T cell independent[J]. J Invest Dermatol, 2001, 117:999-1001. doi:  10.1046/j.0022-202x.2001.01509.x
    [23] Yamamoto T, Nishioka K. Animal model of sclerotic skin. Ⅵ:Evaluation of bleomycin-induced skin sclerosis in nude mice[J]. Arch Dermatol Res, 2004, 295:453-456. doi:  10.1007/s00403-003-0439-y
    [24] Kovacs EJ. Fibrogenic cytokines:the role of immune mediators in the development of scar tissue[J]. Immunol Today, 1991, 12:17-23. doi:  10.1016/0167-5699(91)90107-5
    [25] Yamamoto T, Takahashi Y, Takagawa S, et al. Animal model of sclerotic skin. Ⅱ:Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice[J]. J Rheumatol, 1999, 26:2628-2634. http://www.ncbi.nlm.nih.gov/pubmed/10606374
    [26] Roberts AB, Sporn MB. The transforming growth factors-β[M]//Sporn MB, Roberts AB, eds. Handbook of experimental pharmacology. Heidelberg: Springer-Verlag, 1990: 419-472.
    [27] Takagawa S, Lakos G, Mori Y, et al. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma[J]. J Invest Dermatol, 2003, 121:41-50. doi:  10.1046/j.1523-1747.2003.12308.x
    [28] Nakao A, Fujii M, Matsumura R, et al. Transient gene transfer and expression of Smad 7 prevents bleomycin-induced lung fibrosis in mice[J]. J Clin Invest, 1999, 104:5-11. doi:  10.1172/JCI6094
    [29] Azuma A, Takahashi S, Nose M, et al. Role of E-selectin in bleomycin induced lung fibrosis in mice[J]. Thorax, 2000, 55:147-152. doi:  10.1136/thorax.55.2.147
    [30] Sambo P, Baroni SS, Luchetti M, et al. Oxidative stress in scleroderma:maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway[J]. Arthritis Rheum, 2001, 44:2653-2664. doi:  10.1002/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1
    [31] Sambo P, Jannino L, Candela M, et al. Monocytes of patients with systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion[J]. J Invest Dermatol, 1999, 112:78-84. doi:  10.1046/j.1523-1747.1999.00476.x
    [32] Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals[J]. Biochem J, 1990, 265:659-665. doi:  10.1042/bj2650659
    [33] Falanga V, Martin TA, Takagi H, et al. Low oxygen tension increases mRNA levels of alpha 1(Ⅰ) procollagen in human dermal fibroblasts[J]. J Cell Physiol, 1993, 157:408-412. doi:  10.1002/jcp.1041570225
    [34] Yamamoto T, Nishioka K. Cellular and molecular mechanisms of bleomycin-induced murine scleroderma:current update and future perspective[J]. Exp Dermatol, 2005, 14:81-95. doi:  10.1111/j.0906-6705.2005.00280.x
    [35] Kuwano K, Hagimoto N, Kawasaki M, et al. Essential role of the Fas-Fas ligand pathway in the development of pulmonary fibrosis[J]. J Clin Invest, 1999, 104:13-19. doi:  10.1172/JCI5628
    [36] Yamamoto T, Yokozeki H, Nishioka K. Fas-and FasL-deficient mice are resistant to the induction of bleomycin-induced scleroderma[J]. Arch Dermatol Res, 2007, 298:465-468. doi:  10.1007/s00403-006-0712-y
    [37] Yamamoto T, Takagawa S, Katayama I, et al. Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma[J]. Clin Immunol, 1999, 92:6-13. doi:  10.1006/clim.1999.4720
    [38] Wu MH, Yokozeki H, Takagawa S, et al. Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma[J]. Gene Ther, 2004, 11:170-180. doi:  10.1038/sj.gt.3302165
    [39] Kohno S, Endo H, Hashimoto A, et al. Inhibition of skin sclerosis by 15 deoxy delta 12, 14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma[J]. Biomed Pharmacother, 2006, 60:18-25. doi:  10.1016/j.biopha.2005.04.004
    [40] Terao M, Murota H, Kitaba S, et al. Tumor necrosis factor-alpha processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma[J]. Exp Dermatol, 2010, 19:38-43. doi:  10.1111/j.1600-0625.2009.00973.x
    [41] Kitaba S, Murota H, Terao M, et al. Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma[J]. Am J Pathol, 2012, 180:165-176. doi:  10.1016/j.ajpath.2011.09.013
    [42] Kokot A, Sindrilaru A, Schiller M, et al. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma:melanocortin peptides as a novel treatment stra-tegy for scleroderma?[J]. Arthritis Rheum, 2009, 60:592-603. doi:  10.1002/art.24228
    [43] Koca SS, Isik A, Ozercan IH, et al. Effectiveness of etanercept in bleomycin-induced experimental scleroderma[J]. Rheumatology (Oxford), 2008, 47:172-175. http://rheumatology.oxfordjournals.org/content/47/2/172.full
    [44] Ozgen M, Koca SS, Isik A, et al. Methotrexate has no antifibrotic effect in bleomycin-induced experimental scleroderma[J]. J Rheumatol, 2010, 37:678-679. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=1399f515978fe838c5422366ffbf3892
    [45] Ozgen M, Koca SS, Dagli AF, et al. Mycophenolate mofetil and daclizumab targeting T lymphocytes in bleomycin-induced experimental scleroderma[J]. Clin Exp Dermatol, 2012, 37:48-54. doi:  10.1111/j.1365-2230.2011.04201.x
    [46] Kajii M, Suzuki C, Kashihara J, et al. Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced scleroderma[J]. Clin Exp Immunol, 2011, 163:235-241. doi:  10.1111/j.1365-2249.2010.04295.x
    [47] Yamamoto T, Nishioka K. Analysis of the effect of halofuginone on bleomycin-induced scleroderma[J]. Rheumatology (Oxford), 2002, 41:594-596. doi:  10.1093/rheumatology/41.5.594
    [48] Wu M, Melichian DS, Chang E, et al. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma[J]. Am J Pathol, 2009, 174:519-533. doi:  10.2353/ajpath.2009.080574
    [49] Kroft EB, Berkhof NJ, van de Kerkhof PC, et al. Ultraviolet A phototherapy for sclerotic skin diseases:a systematic review[J]. J Am Acad Dermatol, 2008, 59:1017-1030. doi:  10.1016/j.jaad.2008.07.042
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  211
  • HTML全文浏览量:  78
  • PDF下载量:  5
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-02-20
  • 刊出日期:  2014-04-30

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！